ライフサイエンスコーパス: physician scientist

1 challenges in existing training pathways for physician scientists.

2 t aid our generation in becoming independent physician-scientists.

3 ster and to address the needs of the younger physician-scientists.

4 recruitment, and retention of productive VA physician-scientists.

5 l for global public health, typically led by physician-scientists.

6 cine, and an increase in first R01 grants to physician-scientists.

7 al schools across the US to support training physician-scientists.

8 ing future collaborative programs to support physician-scientists.

9 al research have clouded the career path for physician-scientists.

10 As in-training and early-career physician-scientists across the spectrum of the pipeline

11 nt the fundamentally different ways in which physician scientists and litigation attorneys assess and

12 remains one of the premier organizations for physician-scientists and one of most well-respected orga

13 ication of the von Hippel-Lindau (VHL) gene, physicians, scientists and concerned VHL family members

14 d train a generation of medical oncologists, physician scientists, and cancer biologists.

15 implications of losing highly trained women physician scientists, and the institutional and systemic

16 Reports have outlined the challenges facing physician-scientists, and programs have been initiated t

17 ress will be made by continued engagement of physicians, scientists, and patients.

18 Our recommendations require physicians, scientists, and public-policy leaders to coo

19 r biologists, geneticists, physiologists and physician scientists are critical to the investigation o

20 pment of women and underrepresented minority physician scientists are growing, academic promotion rat

21 eer awards from the NIH as men, women MD-PhD physician scientists are less likely to serve as princip

22 Our findings show that physician scientists are less likely to take a major rol

23 n the current pipeline of infectious disease physician scientists are well documented.

24 nges facing the recruitment and retention of physician scientists as career mental health researchers

25 and a marked increase in the average age of physician-scientists, as older investigators have chosen

26 ding two recent meetings (the joint American Physician Scientists Association, American Society of Cl

27 rough my tenure as president of the American Physician Scientists Association, but also with its memb

28 Ross Levine is a physician-scientist at Memorial Sloan Kettering Cancer C

29 address this problem and help sustain young physician-scientists at career transition points at whic

30 te at University Hospitals, Cleveland); Chao Physician Scientist Award (Baylor College of Medicine);

31 Physician scientists bridge the gap between biomedical r

32 orce, not only for advancing the research of physician-scientists, but also for stimulating public ad

33 honorary society, was established to support physician-scientists by serving as a benchmark of excell

34 his association will be a new forum in which physician-scientists can present their work and encourag

35 mbers in training programs, and establishing Physician-Scientist Career Development offices at medica

36 st opaque career stage transitions along the physician-scientist career path, the transition from med

37 ned obstacles to maintaining the pipeline of physician-scientists, classifying them as an endangered

38 the perseverance and comparative success of physician-scientists competing for NIH research (R01) gr

39 Physician-scientists comprise a unique and valuable part

40 As the number of physician-scientists continues to decline, action must b

41 ants DC018371, NS121067, DC016224; Office of Physician-Scientist Development, Burroughs-Wellcome Fund

42 ch of NIMH throughout my 40-year career as a physician scientist; Dilip Jeste, MD, University of Cali

43 he convening of an expert consensus group of physicians, scientists, ethicists, and stakeholders.

44 tion has supported the career development of physician-scientists for the past 100 years.

45 terests in research, to seek transparency in physician scientist funding mechanisms, and to encourage

46 Physician-scientists have made key discoveries that have

47 Physician-scientists have played a prominent role as tho

48 Physician-scientists have responsibilities to humankind

49 I offer thoughts on the extraordinary powers physician-scientists have to enhance or degrade human di

50 ar tumour boards (MTBs) are panels of expert physicians, scientists, health-care providers and patien

51 in academic medicine in general and for the physician-scientist in particular.

52 e article stresses the urgency of supporting physician-scientists in ID, advocating for proactive pre

53 Nurturing the development of cardiovascular physician-scientist investigators is critical for sustai

54 plantation symposium gathered scientists and physician-scientists involved in basic and clinical rese

55 m an inexperienced trainee to an independent physician-scientist is a multifaceted process requiring

56 Therefore, the decreasing number of physician-scientists may cause medicine to become a tech

57 view integrates viewpoints of biologists and physician-scientists on core pathways involved in fibros

58 As academic physician-scientists, one of the most important things w

59 duation medical education (GME), training of physician scientists, organization of the continuity cli

60 n Viny discusses the emotional toll faced by physician-scientists over this past year and highlights

61 changes will lead to further drop-off in the physician scientist pipeline in a field that has a perpe

62 and hugely successful effort on the part of physicians, scientists, public health experts, community

63 The number of physician scientists receiving postdoctoral research tra

64 Physician scientists (researchers with either M.D. or M.

65 ations, the entire continuum of training for physician-scientists should be reexamined, from the firs

66 programs serve an important role in training physician-scientists, so it is critical to ensure that M

67 leading academic research organizations and physician-scientists specializing in MV disease from the

68 ology by engaging patients, nuclear medicine physicians, scientists, technologists, and referring pro

69 For physician-scientists, the additional role in clinical ca

70 For many young physician-scientists, the American Society for Clinical

71 For many academic physician-scientists, the yearly Tri-Societies meeting o

72 ed with currently used approaches challenges physician-scientists to develop more innovative and effe

73 diology; 4) major reasons for the failure of physician-scientists to receive funding from National In

74 Physician scientists today, on average, receive their fi

75 that prompts young physicians to abandon the physician-scientist track.

76 experience, which should have relevance for physician-scientist trainees, those considering that pat

77 sed internal medicine residency programs, or physician-scientist training programs (PSTPs).

78 A panel of volunteer expert physician scientists were appointed to update the 2020 c

79 maintaining or expanding national needs for physician-scientists where training resource requirement

80 Griffin, a highly accomplished physician-scientist who greatly heightened our understan

81 As a physician-scientist who was born in Iran and immigrated

82 Physician-scientists who become parents during their lon

83 the scientific careers of a large number of physician-scientists who have remained devoted to the mi

84 of myocarditis was hypothesized by the first physician-scientists who noted the conspicuous absence o

85 f tuberculosis; and the arrival of pulmonary physician-scientists who sought enrichment through a pro

86 Physician-scientists, who study the pathogenesis of dise

87 Physician-scientists, with in-depth training in both med

88 nces in biomedical research require a robust physician scientist workforce.

89 The 2014 NIH Physician-Scientist Workforce (PSW) Working Group report

90 e findings illustrate that inequities in the physician-scientist workforce began early in training an

91 earch participation to assess changes in the physician-scientist workforce from 2011-2020.

92 Despite a recommendation by the Physician-Scientist Workforce in 2014 to create "real-ti

93 The paper analyzes the physician-scientist workforce's struggles, including fun

94 needed to fully understand the status of the physician-scientist workforce, and to assess efforts to

95 l opportunities to ensure a more sustainable physician-scientist workforce.

96 expected to play a major role in the future physician-scientist workforce.

97 may promote the future success of a diverse physician-scientist workforce.